A detailed history of Penserra Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 2,191 shares of MRK stock, worth $219,231. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,191
Previous 1,014,418 99.78%
Holding current value
$219,231
Previous $126 Million 99.8%
% of portfolio
0.01%
Previous 1.59%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $113 Million - $131 Million
-1,012,227 Reduced 99.78%
2,191 $248,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $28.3 Million - $30.4 Million
228,418 Added 29.06%
1,014,418 $126 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $9.89 Million - $11.5 Million
-87,295 Reduced 10.0%
786,000 $104 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $21.8 Million - $23.8 Million
-218,074 Reduced 19.98%
873,295 $95.2 Million
Q3 2023

Nov 15, 2023

SELL
$102.95 - $114.33 $14.9 Million - $16.5 Million
-144,292 Reduced 11.68%
1,091,369 $112 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $50.9 Million - $55.4 Million
468,262 Added 61.02%
1,235,661 $143 Million
Q1 2023

Apr 24, 2023

SELL
$102.94 - $114.86 $47.4 Million - $52.9 Million
-460,813 Reduced 37.52%
767,399 $81.6 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $20.9 Million - $26.8 Million
238,981 Added 24.16%
1,228,212 $136 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $24.6 Million - $27.7 Million
291,569 Added 41.79%
989,231 $85.2 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $31.8 Million - $36.1 Million
381,079 Added 120.37%
697,662 $63.6 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $23.3 Million - $26.1 Million
316,583 New
316,583 $26 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $2.76 Million - $3.06 Million
-38,463 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $1.65 Million - $1.87 Million
22,601 Added 142.49%
38,463 $3.19 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $130,277 - $148,240
-1,850 Reduced 10.44%
15,862 $1.23 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $1.05 Million - $1.46 Million
-16,624 Reduced 48.42%
17,712 $1.36 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $886,351 - $1 Million
11,425 Added 49.87%
34,336 $3.12 Million
Q3 2019

Nov 15, 2019

SELL
$76.08 - $82.93 $344,109 - $375,092
-4,523 Reduced 16.49%
22,911 $1.93 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $91,350 - $106,719
1,308 Added 5.01%
27,434 $2.3 Million
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $595,743 - $679,480
8,562 Added 48.75%
26,126 $2.06 Million
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $1.15 Million - $1.33 Million
17,564 New
17,564 $1.34 Million
Q3 2017

Oct 26, 2017

SELL
$58.67 - $63.13 $427,410 - $459,902
-7,285 Closed
0 $0
Q2 2017

Aug 21, 2017

BUY
N/A
7,285
7,285 $466,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.